Share

EORTC & Alliance Boots join forces to support a pan-European biobank for research in advanced colorectal cancer

EORTC Biobanking Project

About the Biobanking Project

  • The EORTC aims to create Europe’s first Biobank for the study of colorectal cancers.
  • This is a unique scientific pan-European initiative, building on the mapping of the human genome.
  • The Biobank will be a leading force in the new phase of progress in cancer treatment.

“The EORTC needs to make this biobank a reality to help patients, present and future, who suffer from cancer.”

A Pan-European Partnership

The EORTC Charitable Trust and Alliance Boots are working to:

  • Raise 5 million euros over the next 5 years
  • Create a Biobank for Colorectal Cancer Tissues
  • Set up a DNA Biobank

Back to news list

Related News

  • EORTC: Advancing research and treatment for rare cancers

  • EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration

  • Appointment of Malte Peters as EORTC Strategic Alliance Officer

  • Unique series of workshops in partnership with the European Medicines Agency (EMA)

  • EORTC launches a prominent clinical trial in older patients with locally advanced (LA) HNSCC (Head and Neck Squamous Cell Carcinoma)

  • Seven IMMUcan abstracts selected for ESMO Immuno-Oncology Congress 2023

  • EORTC Quality of Life measures integrated in CDISC

  • EORTC and Immunocore are collaborating to launch the ATOM clinical trial of tebentafusp in Adjuvant Uveal Melanoma

  • Treatment with decitabine resulted in a similar survival and fewer adverse events compared with conventional chemotherapy in older fit patients with acute myeloid leukaemia

  • New results and forthcoming EORTC trials in rare cancers, lung, head and neck, and breast carcinomas presented at ESMO 2023